| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 31,144 | 35,618 | 85 | 2,561 | | Cost of Revenue | (25,346) | 25,346 |
-
| (50,801) | | | Gross Profit | 56,490 | 10,272 | 85 | 53,362 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 47,567 | 900 | 5,257 | 58,370 | | Non Recurring | 7,478 |
-
|
-
| 12,795 | | Others | 1,606 | 1,617 | 1,565 | 1,770 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (161) | 7,755 | (6,737) | (19,573) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (99) | 4 | 14 | | Earnings Before Interest And Taxes | (161) | 7,656 | (6,733) | (19,559) | | Interest Expense | (244) | 735 | 784 | 960 | | Income Before Tax | 83 | 6,921 | (7,517) | (20,519) | | Income Tax Expense | 607 | 3,033 | (2,829) | (8,442) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (524) | 3,888 | (4,688) | (12,077) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (524) | 3,888 | (4,688) | (12,077) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($524) | $3,888 | ($4,688) | ($12,077) |
|
0.03% Nasdaq 0.00%
Income Statement
